Determination of rivaroxaban in patient’s plasma samples by anti-Xa chromogenic test associated to High Performance Liquid Chromatography tandem Mass Spectrometry (HPLC-MS/MS)

• Priscilla Bento Matos Derogis,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Livia Rentas Sanches,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Valdir Fernandes de Aranda,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Marjorie Paris Colombini,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Cristóvão Luis Pitangueira Mangueira,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Marcelo Katz,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Adriana Caschera Leme Faulhaber,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Claudio Ernesto Albers Mendes,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Carlos Eduardo dos Santos Ferreira,

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯
• Carolina Nunes França,

  Affiliation Santo Amaro University–UNISA, São Paulo, Brazil

  ⨯
• João Carlos de Campos Guerra

  * E-mail: joao.guerra@einstein.br

  Affiliation Hospital Israelita Albert Einstein, São Paulo, Brazil

  ⨯